Sector valuations Arrowhead Pharmaceuticals, Inc.
Equities
ARWR
US04280A1007
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.93 USD | +2.12% |
|
+3.21% | -0.69% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -18.61x | 16.57x | -0x | 20.85x | -26.36x | -18.88x | -.--% | 9.06B | |
| 44.66x | 7.06x | 1.99x | 10.63x | 38.02x | 39.24x | 0.02% | 48.01B | |
| 17.33x | 4.13x | 0.23x | 6.12x | 13.66x | 15.12x | 1.66% | 41.97B | |
| -27.95x | 95.43x | -3.61x | 64.09x | -31.24x | -30.2x | -.--% | 35.77B | |
| -25.81x | 1.18x | -1.15x | 4.22x | -11.51x | -9.1x | -.--% | 25.64B | |
| 18.4x | 3.48x | -5.75x | 4.69x | 12.29x | 13.17x | -.--% | 20.81B | |
| 31.13x | 2.88x | 0.81x | 6.14x | 17.01x | 21.19x | -.--% | 19.92B | |
| -13.07x | - | -0.04x | 163.98x | -25.57x | -12.73x | -.--% | 13.14B | |
| -510.23x | 13.71x | 8.08x | 30x | 534.65x | -584.28x | -.--% | 14.9B | |
| -212.66x | 26.07x | -2.7x | 50.74x | -205.58x | -182.05x | -.--% | 14.63B | |
| 17.03x | 4.54x | 0.36x | 4.86x | 11.99x | 13.32x | -.--% | 11.86B | |
| -48.51x | 19.21x | 0.93x | 11.65x | -45.47x | -43.69x | -.--% | 11.59B | |
| -17.33x | 7.47x | -0.38x | - | -17.75x | -17.15x | -.--% | 7.7B | |
| 852.61x | 44.95x | -7.08x | 102.91x | 925.73x | 1197.5x | - | 7.57B | |
| -10.17x | -14.08x | -0.49x | 92.37x | -12.44x | -12.19x | -.--% | 7.9B | |
| -139.07x | 20.65x | 1.78x | 18.59x | 525.69x | -126.05x | -.--% | 7.25B | |
| 24.65x | 6.8x | 0.71x | - | - | - | - | 6.81B | |
| Average | -1.04x | 16.25x | -0.37x | 39.45x | 106.44x | 16.45x | 0.11% | 17.91B | |
| Weighted average by Cap. | -12.47x | 19.15x | -0.34x | 30.19x | 54.29x | -7.49x | 0.24% |
- Stock Market
- Equities
- ARWR Stock
- Sector Arrowhead Pharmaceuticals, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition